"An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials

被引:0
|
作者
Fatola, Omolayo [1 ]
Corneli, Amy [2 ,3 ]
Perry, Brian [2 ]
Hanlen-Rosado, Emily [2 ]
Nsonwu, Adora [2 ]
Constantine, Evangelia P. [4 ]
Thompson, Amelia B. [5 ,6 ,7 ]
机构
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[2] Duke Univ, Dept Populat Hlth Sci, Sch Med, Durham, NC USA
[3] Duke Univ, Duke Clin Res Inst, Sch Med, Durham, NC USA
[4] Dartmouth Coll, Hanover, NH 03755 USA
[5] Duke Univ, Duke Human Vaccine Inst, Sch Med, Durham, NC USA
[6] Duke Univ, Dept Pediat, Div Infect Dis, Sch Med, Durham, NC USA
[7] AdventHlth Children, Div Infect Dis, Dept Pediat, Orlando, FL 32803 USA
关键词
adolescent; HIV; prevention; vaccine; VISP;
D O I
10.1093/jpids/piac001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Our study explores the understanding of vaccine-induced seropositivity (VISP) and its potential impact on US adolescents' and caregivers' willingness to participate in adolescent HIV vaccine clinical trials. Findings from in-depth interviews suggest that addressing concerns about VISP will be essential for future pediatric HIV vaccine trials in the United States. Addressing adolescents' and their caregivers' concerns about vaccine-induced seropositivity will likely be essential to the success of future pediatric HIV vaccine trials in the United States.
引用
收藏
页码:221 / 224
页数:4
相关论文
共 50 条
  • [41] Ethical-legal challenges in adolescent HIV vaccine trials
    Slack, Catherine
    Strode, Ann
    Mamashela, Mothokoa
    SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2007, (27) : 12 - 13
  • [42] HIV-1 infections during vaccine trials: Identifying new epitopes for differential diagnosis of HIV-1 infections in the face of vaccine-induced antibodies
    Golding, Hana
    Needham, James
    Khurana, Surender
    RETROVIROLOGY, 2005, 2 (Suppl 1)
  • [43] VACCINE-INDUCED RABIES IN A CAT
    BARNES, LE
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1984, 184 (04): : 380 - 380
  • [44] HIV vaccine clinical trials: Experience of the NIAID AIDS vaccine evaluation group
    Fast, PE
    RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES, 1996, : 283 - 290
  • [45] VACCINE-INDUCED POLIOENCEPHALOMYELITIS IN SCOTLAND
    ASINDI, AA
    BELL, EJ
    BROWNING, MJ
    STEPHENSON, JB
    SCOTTISH MEDICAL JOURNAL, 1988, 33 (04) : 306 - 307
  • [46] Vaccine-induced necrobiotic granuloma
    Ajithkumar, K
    Anand, U
    Pulimood, S
    Chandi, SM
    George, S
    Jacob, CK
    Thomas, PP
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1998, 23 (05) : 222 - 224
  • [47] VACCINE-INDUCED OUTBREAKS OF DISEASE
    KEISTER, DM
    VETERINARY MEDICINE & SMALL ANIMAL CLINICIAN, 1982, 77 (04): : 484 - &
  • [48] Correlates of vaccine-induced immunity
    Plotkin, Stanley A.
    CLINICAL INFECTIOUS DISEASES, 2008, 47 (03) : 401 - 409
  • [49] Vaccine-induced autoimmunity in the dog
    Hogenesch, H
    Azcona-Olivera, J
    Scott-Moncrieff, C
    Snyder, PW
    Glickman, LT
    ADVANCES IN VETERINARY MEDICINE, VOL 41: VETERINARY VACCINES AND DIAGNOSTICS, 1999, 41 : 733 - 747
  • [50] Vaccine-Induced Myocarditis: Correspondence
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    PREHOSPITAL AND DISASTER MEDICINE, 2022, 37 (05) : 718 - 718